UCLA scientists engineer potent immune cells for “off-the-shelf” cancer immunotherapy

UCLA researchers awarded $4M to advance immunotherapy treatment for pancreatic cancer

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center were awarded a $4 million grant from NCI to help advance immune-based therapies to improve treatments and outcomes for people diagnosed with pancreatic ductal adenocarcinoma.

July 26, 2024

Vol.50 No.30

Clinical Roundup

AI enhances physicians’ ability to identify extent of prostate cancer with 84% accuracy

Unfold AI is better at identifying cancer margins in the prostate than physicians identifying margins by sight, according to a new study. This AI improves accuracy from 67% to 84%, giving physicians more clarity and treatment planning, allowing them to better recommend therapies tailored to each patient.

July 19, 2024

Vol.50 No.29

In Brief

Linda Liau elected to Taiwan’s Academia Sinica

Linda Liau, chair of neurosurgery at the David Geffen School of Medicine at UCLA, was elected as an Academician of Academia Sinica by the 35th Convocation of Academicians, the preeminent academic institution in Taiwan.

July 12, 2024

Vol.50 No.28

In Brief

UCLA radiation oncologists awarded $1.8M to advance personalized cancer therapy

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have received a $1.8 million grant from NCI to advance their work in personalizing cancer treatment.

July 12, 2024

Vol.50 No.28

In Brief

Sanaz Memarzadeh receives $4.1M to develop immune therapies for ovarian cancer

Sanaz Memarzadeh of UCLA has received two grants totaling $4.1 million to develop advanced cell-based immune therapies for high-grade serous ovarian cancers that have become resistant to conventional treatments.

July 12, 2024

Vol.50 No.28

Clinical Roundup

Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors

Both Tai Chi and cognitive behavioral therapy can reduce insomnia in breast cancer survivors but also may provide additional health benefits by reducing inflammation and bolstering anti-viral defenses, according to a study led by UCLA Health researchers. The work was published in Brain, Behavior, and Immunity.

June 28, 2024

Vol.50 No.26

UCLA scientists engineer potent immune cells for “off-the-shelf” cancer immunotherapy

YOU MAY BE INTERESTED IN

UCLA researchers awarded $4M to advance immunotherapy treatment for pancreatic cancer

AI enhances physicians’ ability to identify extent of prostate cancer with 84% accuracy

Linda Liau elected to Taiwan’s Academia Sinica

UCLA radiation oncologists awarded $1.8M to advance personalized cancer therapy

Sanaz Memarzadeh receives $4.1M to develop immune therapies for ovarian cancer

Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors

Renew today!

Subscriber content

Login